Frontlight ResearchEarly access
Lung cancer trials in United States
900 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peoplePembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
- Where
- Albuquerque, Bethlehem, Burbank, Chicago, Columbus, Golden, Grand Junction, Hackensack, Houston, Little Rock, Marietta, Minneapolis, Newnan, Orange City, Pennington, Philadelphia, San Antonio, San Diego, Washington D.C., Ypsilanti
- Age
- 18 years and over
- People
- 851 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06422143 · EU 2023-510128-66-00 - Phase 2Taking people18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
- Where
- Bethesda
- Age
- 18 years to 120 years
- People
- 320
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06503146 - Phase 3Taking peopleA Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
- Where
- Alexandria, Anaheim, Athens, Atlanta, Baltimore, Baton Rouge, Bay Pines, Bend, Bethesda, Beverly Hills, Boise, Bridgeton, Buffalo, Camden, Chattanooga, Chicago, Cincinnati, Columbia, Covington, Decatur, Detroit, Duluth, East Syracuse, Fairfax, Fort Lauderdale, Fort Wayne, Fort Worth, Fredericksburg, Gainesville, Grand Forks, Grand Rapids, Hershey, Hinsdale, Houston, Jacksonville, Kansas City, Kingwood, Lexington, Lincoln, Loma Linda, Los Alamitos, Louisville, Lubbock, Medford, Nashville, Newark, Olympia, Quincy, Redlands, Rochester, Rockford, Round Rock, Saginaw, Salem, San Francisco, Savannah, Scarborough, Seattle, Shreveport, Silverdale, Sioux Falls, Spokane, Springdale, Tacoma, Tucson, Walnut Creek, Waterloo, Wenatchee, Westbury, West Haven, Wilson, York
- Age
- 18 years and over
- People
- 1,160 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06692738 · EU 2024-514281-39-00 - Phase 1Taking peopleA Phase 1 Study of LNCB74 in Advanced Solid Tumors
- Where
- Boston, Buffalo, Cleveland, Edgewood, Falls Church, Hackensack, Houston, Nashville, Newport Beach, New York, Philadelphia, Pittsburgh, Salt Lake City, San Antonio, St Louis
- Age
- 18 years and over
- People
- 145
- Run by
- LigaChem Biosciences, Inc.
See details and how to joinNCT06774963 - Phase 2Taking peopleCemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer
- Where
- Jacksonville, Rochester
- Age
- 18 years and over
- People
- 60
- Run by
- Mayo Clinic
See details and how to joinNCT06918132 - Phase 2Taking peopleDB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
- Where
- Anderson, Atlanta, Bethesda, Charleston, Florida City, Houston, Lincoln, Los Angeles, New York, Portland, Puyallup, Spokane, Virginia Beach, Wheat Ridge
- Age
- 18 years and over
- People
- 750 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT06953089 · EU 2025-523895-22-00 - Phase 1Taking peopleA Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
- Where
- Atlanta, Buffalo, Cleveland, Fairfax, Grand Rapids, Hackensack, Irving, Jefferson, New York, Santa Monica, St Louis
- Age
- 18 years and over
- People
- 404 worldwide
- Run by
- Astellas Pharma Inc
See details and how to joinNCT07094204 · EU 2025-522082-29-00 - No phaseTaking peopleA Restorative Justice-Based Lung Cancer Screening Decision-Making Support Intervention Tailored for Black Individuals to Increase Lung Cancer Screening Among Black Community Members, RESTORE Trial
- Where
- Seattle
- Age
- 50 years to 77 years
- People
- 45
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT07490860 - Phase 1Taking peopleAutologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease
- Where
- Bethesda
- Age
- 18 years to 120 years
- People
- 40
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT07509034 - No phaseEnrolling by invitationPatient Reported Outcomes Following Percutaneous Lung Ablation
- Where
- Rochester
- Age
- 18 years and over
- People
- 50
- Run by
- Mayo Clinic
See details and how to joinNCT07720102 - Phase 1/2Taking peopleSumMET: Study of [225Ac]Ac-FL-261 in Participants With Solid Tumors Overexpressing c-MET
- Where
- Minneapolis
- Age
- 18 years and over
- People
- 208 worldwide
- Run by
- Full-Life Technologies UK Limited
See details and how to joinNCT07873450 - No phaseTaking peopleAvera Cancer Sequencing and Analytics Protocol (ASAP)
- Where
- Aberdeen, Marshall, Mitchell, Pierre, Sioux Falls, Yankton
- Age
- 18 years and over
- People
- 25,000
- Run by
- Avera McKennan Hospital & University Health Center
See details and how to joinNCT05142033 - Phase 1Taking peopleKK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
- Where
- New Brunswick
- Age
- 18 years and over
- People
- 30
- Run by
- Christian Hinrichs
See details and how to joinNCT05483491 - Phase 2Taking peopleBiologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) to Tyrosine Kinase Inhibitor in Oligoprogressive Oncogenic Positive Non-Small Cell Lung Carcinoma
- Where
- Duarte, New Haven
- Age
- 18 years and over
- People
- 32
- Run by
- City of Hope Medical Center
See details and how to joinNCT06014827 - Phase 1Taking peopleA Study of MGC026 in Participants With Advanced Solid Tumors
- Where
- Grand Rapids, Houston, Lake Success, Los Angeles, Portland, West Valley City
- Age
- 18 years and over
- People
- 394 worldwide
- Run by
- MacroGenics
See details and how to joinNCT06242470 - Phase 3Taking peoplePhase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
- Where
- Anaheim, Anchorage, Annapolis, Appleton, Atlanta, Beverly Hills, Boston, Bozeman, Chattanooga, Cincinnati, Clermont, Columbus, Dearborn, Farmington Hills, Fort Belvoir, Fort Worth, Fountain Valley, Gainesville, Grand Island, Grand Rapids, Greenville, Hattiesburg, Hinsdale, Houston, Kansas City, Kingwood, Knoxville, Las Vegas, Leesburg, Little Rock, Maumee, Miami Beach, Midlothian, Newport Beach, Noblesville, Odessa, Omaha, Orange City, Orlando, Paducah, Portland, Reno, Richmond, Salisbury, Sioux Falls, Springdale, Stony Brook, Tacoma, Toledo, Traverse City, Tucson, Vancouver, Voorhees Township, Wenatchee, West Palm Beach
- Age
- 18 years and over
- People
- 675 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06357533 · EU 2023-505077-32-00 - Phase 3Taking peopleA Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC
- Where
- Alexandria, Anaheim, Atlanta, Baltimore, Baton Rouge, Bay Pines, Bethesda, Beverly Hills, Boise, Bridgeton, Buffalo, Camden, Canton, Chandler, Chattanooga, Chicago, Columbia, Decatur, Duluth, Fairfax, Fort Lauderdale, Fort Worth, Gainesville, Grand Rapids, Hinsdale, Houston, Irving, Jacksonville, Kingwood, La Crosse, Lexington, Lincoln, Loma Linda, Lone Tree, Louisville, Lubbock, Medford, Miami, Mobile, Nashville, Newark, Norfolk, Ocala, Palestine, Phoenix, Pierre, Pittsburgh, Portland, Providence, Quincy, Redlands, Roanoke, Rochester, Rockford, Round Rock, Saint Paul, Salem, San Diego, San Francisco, Santa Rosa, Seattle, Shreveport, Silverdale, Sioux Falls, South Portland, Spokane, Stamford, St. Petersburg, Tacoma, Walnut Creek, Waterloo, Wenatchee, Westbury, West Haven, York
- Age
- 18 years and over
- People
- 1,160 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06627647 · EU 2024-515008-38-00 - Phase 2Taking peopleA Study of Stereotactic Radiosurgery (SRS) and Standard Treatment in People With Lung Cancer That Has Spread to the Brain
- Where
- Basking Ridge, Commack, Harrison, Miami, Middletown, Montvale, New York, Rockville Centre
- Age
- 18 years and over
- People
- 56
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06741085 - Phase 1/2Taking peopleA Study to Investigate ALE.P02 as a Monotherapy or in Combination With Pembrolizumab in Adult Patients With Selected CLDN1+ Solid Tumors
- Where
- Chicago, Fairfax, Fullerton, Hackensack, Los Angeles, Louisville, New Haven, Scottsdale
- Age
- 18 years and over
- People
- 235 worldwide
- Run by
- Alentis Therapeutics AG
See details and how to joinNCT06747585 · EU 2024-515459-39-00 - Phase 1/2Taking peopleA Platform Study in Non-Small Cell Lung Cancer (NSCLC)
- Where
- Baltimore, Cleveland, Detroit, Jacksonville, Phoenix, Providence, Rochester, Santa Rosa, Tyler
- Age
- 18 years and over
- People
- 152 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06996782 · EU 2024-519786-22-01 - Phase 1/2Taking peopleA Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- Where
- Austin, Boston, Cleveland, Duarte, Fairfax, Houston, Huntersville, Irvine, Milwaukee, Nashville, Omaha, Orlando, Rochester, San Antonio, St Louis, West Valley City, Zion
- Age
- 18 years and over
- People
- 248 worldwide
- Run by
- Terremoto Biosciences Inc.
See details and how to joinNCT07109726 - Phase 4Taking peopleAn Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd) -Related Stomatitis in Eligible Patients With Metastatic or Inoperable Locally Recurrent Breast Cancer or Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-small Cell Lung Cancer.
- Where
- Athens, Boise, Charleston, Cleveland, Coral Springs, Detroit, Duarte, East Syracuse, Elizabethtown, Fairfax, Fort Wayne, Frederick, Glendale, Glenn Dale, Grayling, Greensboro, Hot Springs, Kansas City, Knoxville, Lakewood, Lebanon, Lexington, Little Rock, Long Beach, Louisville, Minneapolis, Morgantown, New Orleans, Park Ridge, Plantation, Reno, Torrance, Tucson, Washington D.C., Waukesha, Westbury, West Columbia, White Plains, Wilson, Wynnewood
- Age
- 18 years and over
- People
- 100
- Run by
- AstraZeneca
See details and how to joinNCT07357597 - No phaseTaking peopleA Study of a Side Effects and Resource Navigation Program for People With Cancer
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Rockville Centre
- Age
- 18 years and over
- People
- 200
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07646847 - Phase 1Not yet taking people in United StatesA Phase 1a/1b Of Zanidatamab In Combination With Zongertinib In HER2-Mutated Non-Small Cell Lung Cancer (NSCLC)
- Where
- Houston
- Age
- 18 years and over
- People
- 24
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07899801 - Phase 1/2Taking peoplePET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- Where
- New York
- Age
- 18 years and over
- People
- 105
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT04199741